Inhibition of EZH2 Degradation as a Novel Approach to Overcome Drug Resistance in Acute Myeloid Leukemia

Molecular and Cellular Oncology - United Kingdom
doi 10.1080/23723556.2017.1291396
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Dual Roles of EZH2 in Acute Myeloid Leukemia

Journal of Experimental Medicine
MedicineAllergyImmunology
2019English

Tipifarnib and Bortezomib Are Synergistic and Overcome Cell Adhesion-Mediated Drug Resistance in Multiple Myeloma and Acute Myeloid Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2006English

Novel Agents in Acute Myeloid Leukemia

International Journal of Hematology
Hematology
2012English

Tyrosine Kinase Inhibition in Acute Myeloid Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

The Clinical Relevance of Cellular Drug Resistance Testing in Childhood Acute Myeloid Leukemia (AML)

Pediatric Research
Child HealthPediatricsPerinatology
1999English

Histone Deacetylase 1 Induced by Neddylation Inhibition Contributes to Drug Resistance in Acute Myelogenous Leukemia

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2019English

Inhibition of BCL-xL Overcomes Polyploidy Resistance and Leads to Apoptotic Cell Death in Acute Myeloid Leukemia Cells

Oncotarget
Oncology
2015English

WTAP Is a Novel Oncogenic Protein in Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy